Oral tetrahydrouridine and decitabine for non-cytotoxic epigenetic gene regulation in sickle cell disease: A randomized phase 1 study
Robert Molokie, Donald Lavelle, Michel Gowhari et al. · PLOS Medicine · 2017 · Randomised trial
Full textCC0
13 papers3 CorrectedQuestions on this topic
Robert Molokie, Donald Lavelle, Michel Gowhari et al. · PLOS Medicine · 2017 · Randomised trial
Full textCC0
Eleanor Wheeler, Aaron Leong, Ching-Ti Liu et al. · PLOS Medicine · 2017 · Meta-analysis
Full textCC0
Akbar K. Waljee, Wyndy L. Wiitala, Shail Govani et al. · PLOS ONE · 2016
Full textCC0
Li Ma, Jeffrey R. O'Connell, Paul M. VanRaden et al. · PLOS Genetics · 2015
Full textCC0
Von Mark V. Cruz, Andrzej Kilian, David A. Dierig · PLoS ONE · 2013
Full textCC0
Conall M. O'Seaghdha, Hongsheng Wu, Qiong Yang et al. · PLoS Genetics · 2013 · Meta-analysis
Full textCC0
Carolina Pardo-Diaz, Camilo Salazar, Simon W. Baxter et al. · PLoS Genetics · 2012
Full textCC0
Shashaank Vattikuti, Juen Guo, Carson C. Chow · PLoS Genetics · 2012
Full textCC0
Thomas O. Crawford, Sergey V. Paushkin, Dione T. Kobayashi et al. · PLoS ONE · 2012
Full textCC0
Pedro Cardoso, Stano Pekár, Rudy Jocqué et al. · PLoS ONE · 2011
Full textCC0
Keyan Zhao, Mark Wright, Jennifer Kimball et al. · PLoS ONE · 2010
Full textCC0
Xiao Ou Shu, Jirong Long, Qiuyin Cai et al. · PLoS Genetics · 2010
Full textCC0
M. Kamran Ikram, Sim Xueling, Richard A. Jensen et al. · PLoS Genetics · 2010
Full textCC0